J. Goldman & Co LP - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 52 filers reported holding LEAP THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$284,000
-83.8%
162,000
-70.0%
0.01%
-86.5%
Q4 2021$1,750,000
+12.3%
540,000
-31.4%
0.10%
-9.4%
Q3 2020$1,559,000
-26.7%
787,326
-22.7%
0.11%
-19.7%
Q2 2020$2,128,0001,018,2850.13%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders